New Delhi-based startup BeatO has announced the acquisition of Pune-based Novique Health for an undisclosed amount. BeatO provides a full-stack solution for diabetes management and, with Novique, will now also provide a science-backed diabetes reversal programme.

Through this acquisition, BeatO will augment its services of combating diabetes through clinically proven management, reduction, and reversal of diabetes by addressing the condition’s root cause.

Commenting on the acquisition, Gautam Chopra, Founder & CEO – BeatO, said, “At BeatO, we have built a data-driven and clinically robust solution for the monitoring and control of diabetes, driving positive health outcomes for our members. With Novique’s acquisition, we will leverage their expertise and scientific approach in reversing Type 2 diabetes, further strengthening BeatO’s clinical programme.”

The funds will be utilised to grow its subscriber base across multiple channels and geographies as well as for product enhancement to provide care for other cardio-metabolic conditions.

The company has currently expanded to 650,000 registered members, out of which 300,000 are paid members serviced across 3,000 cities in India.